Patent classifications
C07D311/80
COMPOSITIONS AND METHODS FOR USE OF CANNABINOIDS FOR NEUROPROTECTION
Provided herein are methods and compositions for neuroprotection. The neuroprotective composition can be or include cannabinol or a derivative thereof. The neuroprotective composition can be used in the treatment of a neurodegenerative disease. The neuroprotective composition can be used to protect retinal neurons from degeneration in a subject in need thereof, such as for treatment of glaucoma.
OXYGEN HETEROCYCLIC COMPOUND, APPLICATION THEREOF AND ELECTRONIC DEVICE USING THE SAME
The present disclosure provides an oxygen heterocyclic compound, an application thereof, and an electronic device using the same. The oxygen heterocyclic compound has a structural formula as represented by following formula 1:
##STR00001##
The oxygen heterocyclic compound comprises an aromatic amine portion and an oxygen heterocyclic portion. The aromatic amine portion effectively promotes the hole injection and transport performance. The oxygen heterocyclic portion is conducive to the formation of molten evaporation materials.
OXYGEN HETEROCYCLIC COMPOUND, APPLICATION THEREOF AND ELECTRONIC DEVICE USING THE SAME
The present disclosure provides an oxygen heterocyclic compound, an application thereof, and an electronic device using the same. The oxygen heterocyclic compound has a structural formula as represented by following formula 1:
##STR00001##
The oxygen heterocyclic compound comprises an aromatic amine portion and an oxygen heterocyclic portion. The aromatic amine portion effectively promotes the hole injection and transport performance. The oxygen heterocyclic portion is conducive to the formation of molten evaporation materials.
Process for producing an extract containing tetrahydrocannabinol and cannabidiol from cannabis plant material, and cannabis extracts
The invention relates to a method for producing an extract from cannabis plant matter, containing tetrahydrocannabinol, cannabidiol and optionally the carboxylic acids thereof. According to said method, the dried plant matter is ground and subjected to a CO.sub.2 extraction and the primary extract obtained is separated. The invention method permits Δ.sup.8 or Δ.sup.9 tetrahydrocannabinol to be selectively obtained both from industrial hemp and from drug-producing hemp, optionally after dissolving the primary extract in ethanol, separating undesirable waxes and removing the solvent under reduced pressure.
Process for producing an extract containing tetrahydrocannabinol and cannabidiol from cannabis plant material, and cannabis extracts
The invention relates to a method for producing an extract from cannabis plant matter, containing tetrahydrocannabinol, cannabidiol and optionally the carboxylic acids thereof. According to said method, the dried plant matter is ground and subjected to a CO.sub.2 extraction and the primary extract obtained is separated. The invention method permits Δ.sup.8 or Δ.sup.9 tetrahydrocannabinol to be selectively obtained both from industrial hemp and from drug-producing hemp, optionally after dissolving the primary extract in ethanol, separating undesirable waxes and removing the solvent under reduced pressure.
ENHANCING AUTOPHAGY OR INCREASING LONGEVITY BY ADMINISTRATION OF UROLITHINS
Disclosed are methods, compounds, and compositions useful for increasing autophagy and promoting longevity. The methods, compounds, and compositions relate to urolithins and urolithin precursors and use thereof. Certain urolithins are represented by Formula I, while certain urolithin precursors are represented by Formula IV. The urolithin may be urolithin A, urolithin B, urolithin C, or urolithin D. The urolithin precursor may be ellagic acid or an ellagitannin. The methods include in vivo, ex vivo, and in vitro uses of the compounds and compositions.
ENHANCING AUTOPHAGY OR INCREASING LONGEVITY BY ADMINISTRATION OF UROLITHINS
Disclosed are methods, compounds, and compositions useful for increasing autophagy and promoting longevity. The methods, compounds, and compositions relate to urolithins and urolithin precursors and use thereof. Certain urolithins are represented by Formula I, while certain urolithin precursors are represented by Formula IV. The urolithin may be urolithin A, urolithin B, urolithin C, or urolithin D. The urolithin precursor may be ellagic acid or an ellagitannin. The methods include in vivo, ex vivo, and in vitro uses of the compounds and compositions.
BIOACTIVE PHENOLATE IONIC COMPLEXES
The invention provides an isolated material, or a phenolate form of at least one phenol- containing active material, wherein the isolated material comprises one or more phenolate species and a counter ion (a cation) in the form of a metal salt, a phosphonium or an ammonium.
BIOACTIVE PHENOLATE IONIC COMPLEXES
The invention provides an isolated material, or a phenolate form of at least one phenol- containing active material, wherein the isolated material comprises one or more phenolate species and a counter ion (a cation) in the form of a metal salt, a phosphonium or an ammonium.
SEPARATION OF CANNABINOIDS FROM MIXTURES THEREOF BY DISTILLATION
The present disclosure relates to isolating one or more cannabinoids from an input mixture. There is disclosed an apparatus that comprises a volatizing unit, a fractional distillation unit, and a condensing unit. The volatizing unit receives and volatilizes the input mixture to provide a cannabinoid-containing vapor stream and a residue. The fractional distillation unit comprises a plenum for receiving the cannabinoid-containing vapor stream and separates a first cannabinoid from at least a second cannabinoid. The condensing unit is configured to receive a portion of the cannabinoid-containing vapor stream comprising the first cannabinoid from the plenum and to form a condensed first cannabinoid output stream and a recirculate stream. There are also disclosed methods for isolating one or more cannabinoids employing a recirculate stream.